The toxic and hematologic effects of interleukin-1 alpha administered in a phase I trial to patients with advanced malignancies. - Concepedia

Concepedia

Publication | Closed Access

The toxic and hematologic effects of interleukin-1 alpha administered in a phase I trial to patients with advanced malignancies.

166

Citations

29

References

1992

Year

John W. Smith, Walter J. Urba, Brendan D. Curti, L J Elwood, Ronald G. Steis, John E. Janik, William H. Sharfman, L.L. Miller, R. G. Fenton, Kevin C. Conlon

Journal of Clinical Oncology

Abstract

We conclude that at doses of IL-1 alpha that can be given safely to cancer patients, significant, potentially beneficial hematopoietic effects occur.

References

	Year	Citations

Page 1